{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:18:07Z","timestamp":1759940287401,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1208\/s12249-018-1170-5","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:48:10Z","timestamp":1536756490000},"page":"3272-3276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Simple and Rapid Method for Deposition and Measurement of Drug Transport Across Air Interface Respiratory Epithelia"],"prefix":"10.1208","volume":"19","author":[{"given":"Mehra","family":"Haghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-017X","authenticated-orcid":false,"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"issue":"7","key":"1170_CR1","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s11095-013-1282-2","volume":"31","author":"M Haghi","year":"2014","unstructured":"Haghi M, Traini D, Young P. In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers. Pharm Res. 2014;31(7):1779\u201387. \n                    https:\/\/doi.org\/10.1007\/s11095-013-1282-2\n                    \n                  .","journal-title":"Pharm Res"},{"issue":"5","key":"1170_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1023\/A:1023441804464","volume":"20","author":"J Fiegel","year":"2003","unstructured":"Fiegel J, Ehrhardt C, Schaefer UF, Lehr CM, Hanes J. Large porous particle impingement on lung epithelial cell monolayers\u2014toward improved particle characterization in the lung. Pharmaceut Res. 2003;20(5):788\u201396. \n                    https:\/\/doi.org\/10.1023\/A:1023441804464\n                    \n                  .","journal-title":"Pharmaceut Res"},{"issue":"2","key":"1170_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejpb.2008.07.019","volume":"72","author":"M Bur","year":"2009","unstructured":"Bur M, Rothen-Rutishauser B, Huwer H, Lehr CM. A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations. Eur J Pharm Biopharm. 2009;72(2):350\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2008.07.019\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1170_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejpb.2010.10.003","volume":"77","author":"S Hein","year":"2011","unstructured":"Hein S, Bur M, Schaefer UF, Lehr CM. A new pharmaceutical aerosol deposition device on cell cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations. Eur J Pharm Biopharm. 2011;77(1):132\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2010.10.003\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"1170_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/026119290403200609","volume":"32","author":"D Cooney","year":"2004","unstructured":"Cooney D, Kazantseva M, Hickey AJ. Development of a size-dependent aerosol deposition model utilising human airway epithelial cells for evaluating aerosol drug delivery. Atla-Altern Lab Anim. 2004;32(6):581\u201390.","journal-title":"Atla-Altern Lab Anim"},{"key":"1170_CR6","unstructured":"McDonnell C, Shur J, Burns J, Hipkiss D, Price R. Investigation deposition and drug absorption of budesonide microparticles using a cell compatible next generation impactor. In: Publishing DHIl, editor. Respir Drug Deliv USA 2012. p. 785\u2013788."},{"issue":"10","key":"1170_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3109\/03639041003695113","volume":"36","author":"M Haghi","year":"2010","unstructured":"Haghi M, Young PM, Traini D, Jaiswal R, Gong J, Bebawy M. Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model. Drug Dev Ind Pharm. 2010;36(10):1207\u201314. \n                    https:\/\/doi.org\/10.3109\/03639041003695113\n                    \n                  .","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"1170_CR8","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","volume":"23","author":"CI Grainger","year":"2006","unstructured":"Grainger CI, Greenwell LL, Lockley DJ, Martin GP, Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res. 2006;23(7):1482\u201390. \n                    https:\/\/doi.org\/10.1007\/s11095-006-0255-0\n                    \n                  .","journal-title":"Pharm Res"},{"issue":"1","key":"1170_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/10611860290007504","volume":"10","author":"NR Mathias","year":"2002","unstructured":"Mathias NR, Timoszyk J, Stetsko PI, Megill JR, Smith RL, Wall DA. Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Target. 2002;10(1):31\u201340. \n                    https:\/\/doi.org\/10.1080\/10611860290007504\n                    \n                  .","journal-title":"J Drug Target"},{"key":"1170_CR10","first-page":"1","volume":"3","author":"H Exiarch","year":"2010","unstructured":"Exiarch H, Haltner-Ukomadu E, Beisswenger C, Bock U. Drug delivery to the lung: permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS). J Epithelial Biol Pharmacol. 2010;3:1\u201314.","journal-title":"J Epithelial Biol Pharmacol"},{"issue":"1","key":"1170_CR11","doi-asserted-by":"publisher","first-page":"L25","DOI":"10.1152\/ajplung.00256.2010","volume":"300","author":"AA Pezzulo","year":"2011","unstructured":"Pezzulo AA, Starner TD, Scheetz TE, Traver GL, Tilley AE, Harvey BG, et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L25\u201331. \n                    https:\/\/doi.org\/10.1152\/ajplung.00256.2010\n                    \n                  .","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"1170_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejpb.2008.09.006","volume":"71","author":"CI Grainger","year":"2009","unstructured":"Grainger CI, Greenwell LL, Martin GP, Forbes B. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. Eur J Pharm Biopharm. 2009;71(2):318\u201324. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2008.09.006\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1170_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1081\/Ddc-120016682","volume":"29","author":"PGA Rogueda","year":"2003","unstructured":"Rogueda PGA. HPFP, a model propellant for pMDIs. Drug Dev Ind Pharm. 2003;29(1):39\u201349. \n                    https:\/\/doi.org\/10.1081\/Ddc-120016682\n                    \n                  .","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1170_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/03639040903099769","volume":"36","author":"H Adi","year":"2010","unstructured":"Adi H, Young PM, Chan HK, Salama R, Traini D. Controlled release antibiotics for dry powder lung delivery. Drug Dev Ind Pharm. 2010;36(1):119\u201326. \n                    https:\/\/doi.org\/10.3109\/03639040903099769\n                    \n                  .","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"1170_CR15","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1002\/jps.21239","volume":"97","author":"H Adi","year":"2007","unstructured":"Adi H, Young P, Chan HK, Stewart P, Agus H, Traini D. Cospray dried antibiotics for dry powder lung delivery. J Pharm Sci. 2007;97(8):3356\u201366.","journal-title":"J Pharm Sci"},{"key":"1170_CR16","first-page":"37","volume":"1","author":"SA Tolnai","year":"1975","unstructured":"Tolnai SA. Method for viable cell count. Methods Cell Sci. 1975;1:37\u20138.","journal-title":"Methods Cell Sci"},{"issue":"1","key":"1170_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2013.02.020","volume":"86","author":"M Haghi","year":"2014","unstructured":"Haghi M, Bebawy M, Colombo P, Forbes B, Lewis DA, Salama R, et al. Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro. Eur J Pharm Biopharm. 2014;86(1):38\u201345. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2013.02.020\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1170-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:04:30Z","timestamp":1568228670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1170-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1170"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1170-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"7 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}